Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders. Dividend stocks have long been favored by investors for the income ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

The business contact information for 122 million people circulating since February 2024 is now confirmed to have been stolen ...

Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

The new partnership builds on earlier collaborations like the Spokes Project that saw SSPC and NIBRT work with Allergan, ...

Naomi’s most recent, and perhaps most important, contribution to the public debate has been editing the now released ...

Sandoz Inc.’s proposed generic version of Inlyta infringes a patent for the kidney-cancer chemotherapy treatment, Pfizer Inc.

The emergence of concerns surrounding the association between Depo-Provera and severe health risks, including meningioma, ...

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...

Zimmer Biomet has hired The Terminator to tell the world that “if you rest, you rust.” The manufacturer of orthopedic medtech ...

Under the Chips Act the Commerce Dept. has awarded $36 billion to Intel, Micron Technology, and others. But no money has been ...